Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2020

Nov 4, 2020

34472_dirs_2020-11-03_9e2c8d6f-0ed2-478c-9a30-f0fe8d82599c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-06-22

Reporting Person: SCHULER JACK W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-30 Common Stock C 4668046 Acquired 4668046 Indirect
2020-10-30 Common Stock C 245041 Acquired 4913087 Indirect
2020-10-30 Common Stock C 753735 $14.40 Acquired 5666822 Indirect
2020-10-30 Common Stock P 277777 $18.00 Acquired 277777 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-10-30 Series B Preferred Stock $ C 1454545 Disposed Common Stock (245042) Indirect
2020-10-30 Series B-1 Preferred Stock $ C 1250000 Disposed Common Stock (245041) Indirect
2020-10-30 Series C Preferred Stock $ C 333333 Disposed Common Stock (56155) Indirect
2020-10-30 Series D Preferred Stock $ C 3101784 Disposed Common Stock (522546) Indirect
2020-10-30 Series E Preferred Stock $ C 1759853 Disposed Common Stock (296476) Indirect
2020-10-30 Series F Preferred Stock $ C 6273780 Disposed Common Stock (1056921) Indirect
2020-10-30 Series G Preferred Stock $ C 9419362 Disposed Common Stock (1586846) Indirect
2020-10-30 Series H Preferred Stock $ C 5366411 Disposed Common Stock (904060) Indirect
2020-06-22 3% Convertible Debt due June 2021 $ A Acquired 2021-06-30 Common Stock (108564) Indirect
2020-10-30 3% Convertible Debt due June 2021 $14.40 C Disposed 2021-06-30 Common Stock (753735) Indirect

Footnotes

F1: Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred
Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the "Preferred Stock") converted into approximately 0.1684664
shares of Issuer Common Stock ("Common Stock") at the closing of the Issuer's initial public offering ("IPO"). Share numbers give effect to such
conversion. The Preferred Stock had no expiration date.

F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F3: Every share of Series B-1 Preferred Stock ("B-1 Preferred Stock") converted into approximately 0.196 shares of Common Stock at the closing of
the Issuer's IPO. Share numbers give effect to such conversion. The B-1 Preferred Stock had no expiration date.

F4: The Reporting Person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation").
Although the Reporting Person is the President of the Foundation and makes investment decisions regarding the Foundation's securities
transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the Reporting Person may not, and in fact, does not
personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with
respect to these purchases of the Issuer's common stock by the Foundation.

F5: This Convertible Debt paid interest at 3% per annum and was payable in full upon maturity through the conversion to Series H Preferred Stock at
80% of the original issuance price of $1.15 per share. On or before the maturity date and if the Convertible Debt remained unpaid, the
outstanding principal and unpaid accrued interest was to be automatically converted into Common Stock at the completion of the IPO at a
conversion price equal to 80% of the price per share paid for the Common Stock sold in the IPO. Share numbers give effect to such conversion;
debt amount reflects principal only, no interest.

F6: This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule
16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the
Reporting Person's Form 3.

F7: Upon completion of the IPO, the outstanding principal and unpaid accrued interest on this Convertible Debt was automatically converted into
Common Stock. Share numbers gave effect to such conversion; debt amount reflects principal only, no interest.